• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
Gynesonics

Gynesonics

Advancing technology. Improving women's lives.

  • Our Company
    • About Us
    • Compliance and Quality
    • Careers
  • Our People
    • Management
    • Board of Directors
    • Investors
  • Our Technology
    • The Sonata System
    • Indications and Safety
    • Instructions for Use
    • Request for Medical or Scientific Information
  • Our News
    • Press Releases
    • In the News
    • Publications
  • Contact Us

Sonata Treatment and the Future of FemTech

March 11, 2024 by bsmith

Maneesha Ghiya of FemHealth Ventures talks with CNBC’s Women & Wealth to discuss the optimistic future of FemTech. Ghiya shares how nearly dying from complications after childbirth prompted her to create FemHealth Ventures to be a vehicle for funding better diagnostics, research, and treatments for women’s health. Ghiya wraps up the segment by explaining how the average investor can participate in funding FemTech, what investors look for in a company, and by expressing her excitement about the Sonata Treatment, a groundbreaking incisionless treatment option for symptomatic uterine fibroids.

Watch the video on CNBC.com.

Filed Under: News Stories

Primary Sidebar

  • Privacy Notice
  • Cookie Notice
  • Do Not Sell/Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information

© Copyright 2025 Gynesonics · All Rights Reserved · WS 05198 Rev. M

  • Privacy Notice
  • Cookie Notice
  • Do Not Sell/Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information